BRYAN FICHTNER: Open Payments
NPI 1174215867 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Cranial Technologies, Inc | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: XIFAXAN, Ozempic, Doc Band, VYEPTI, TRINTELLIX, VRAYLAR, FARXIGA.
Industry payments across VA — which companies pay providers there.
